Literature DB >> 7525593

T lymphocytes, CD68-positive cells and vascularisation in thyroid carcinomas.

G Herrmann1, P M Schumm-Draeger, C Müller, E Atai, B Wenzel, T Fabian, K H Usadel, K Hübner.   

Abstract

Immunohistochemical detection and quantification of CD3- and CD45RO-positive lymphocytes and CD68-positive cells in 75 thyroid carcinomas of follicular cell origin revealed rising levels for these parameters associated with dedifferentiation. A parallel trend towards reduction of vascularisation, determined as CD31-positive blood vessels, with decreasing differentiation became evident, statistically only significant when well-differentiated follicular and anaplastic carcinomas were compared. Positive correlations could be demonstrated between the density of CD68-, CD3-, and CD45RO-positive cells as well as between the density of CD68-, and CD3-, and CD45RO-positive cells and vascularisation. These correlations were expected, as the interaction of CD68-positive cells and T lymphocytes results in the production of angiogenesis factors, ultimately leading to better vascularisation of the tumour. Nevertheless, the tumour cells themselves are variously capable of producing angiogenic substances. The obvious lack of positive correlation between the density of tumour-infiltrating cells determined in this study and vascularisation, despite reduced vascularisation in less differentiated tumours that contained increasing numbers of tumour-infiltrating cells, seems to be due to functional heterogeneity of morphologically similar tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525593     DOI: 10.1007/bf01245376

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity.

Authors:  S Poppema; R Lai; L Visser
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

2.  Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.

Authors:  S Schröder; V Bay; K Dumke; B Kremens; H W Müller-Gärtner; W Böcker; H Kastendieck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Phenotypic diversity of the CD45 antigen and its relationship to function.

Authors:  P C Beverley; M Merkenschlager; L Terry
Journal:  Immunol Suppl       Date:  1988

5.  Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data.

Authors:  S Schröder; W Schwarz; W Rehpenning; T Löning; W Böcker
Journal:  Am J Clin Pathol       Date:  1988-03       Impact factor: 2.493

6.  Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis.

Authors:  K Inoue; M Furihata; Y Ohtsuki; Y Fujita
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid.

Authors:  H R Harach; B Jasani; E D Williams
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

8.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

9.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules.

Authors:  H C Hsu; T J Chiou; J Y Chen; C S Lee; P H Lee; S Y Peng
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

View more
  10 in total

1.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

Authors:  R P Negus; G W Stamp; J Hadley; F R Balkwill
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.

Authors:  Maureen Moore; Suraj Panjwani; Rashmi Mathew; Michael Crowley; Yi-Fang Liu; Anna Aronova; Brendan Finnerty; Rasa Zarnegar; Thomas J Fahey; Theresa Scognamiglio
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

3.  Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination.

Authors:  C Guertner; B J Krause; H Klepzig; G Herrmann; S Lelbach; E K Vockert; A Hartmann; F D Maul; T W Kranert; E Mutschler
Journal:  Eur J Nucl Med       Date:  1995-05

4.  Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.

Authors:  Ala'eddin Jebreel; James England; Karen Bedford; Justin Murphy; Laszlo Karsai; Stephen Atkin
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

5.  Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.

Authors:  Mabel Ryder; Ronald A Ghossein; Julio C M Ricarte-Filho; Jeffrey A Knauf; James A Fagin
Journal:  Endocr Relat Cancer       Date:  2008-08-21       Impact factor: 5.678

6.  Relationships between Lymph Node Metastasis and Expression of CD31, D2-40, and Vascular Endothelial Growth Factors A and C in Papillary Thyroid Cancer.

Authors:  Sang-Hyuk Lee; Sung-Jin Lee; Sung-Min Jin; No-Hee Lee; Dong-Hoon Kim; Seung-Wan Chae; Jin-Hee Sohn; Won-Serk Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-08-27       Impact factor: 3.372

Review 7.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

8.  Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15.

Authors:  Feng-Jiao Huang; Xiao-Yi Zhou; Lei Ye; Xiao-Chun Fei; Shu Wang; Weiqing Wang; Guang Ning
Journal:  BMC Cancer       Date:  2016-02-15       Impact factor: 4.430

9.  Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis.

Authors:  Konstantinos Perivoliotis; Athina A Samara; Prodromos Koutoukoglou; Panagiotis Ntellas; Katerina Dadouli; Sotirios Sotiriou; Maria Ioannou; Konstantinos Tepetes
Journal:  World J Methodol       Date:  2022-09-20

10.  Angiogenesis in Endocrine Neoplasms.

Authors:  Martin Jugenburg; Kalman Kovacs; Ivan Jugenburg; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.